Atrial Fibrillation: all 3,957 studies
Page 35 of 40. Open to participants first (933), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AFStatus unknownNCT01817439Phase 3
- Cognitive Impairment in Atrial FibrillationStatus unknownNCT01816308
- Renal Sympathetic Denervation in Patients With Hypertension and Paroxysmal Atrial FibrillationStatus unknownNCT01814111Not applicable
- The Concomitant Cryomaze Procedure Using Nitreous Oxide Cryoprobe: Comparison With Argon Based CryoprobeCompletedNCT01812356Not applicable
- Antithrombotic Triple Therapy in HumansCompletedNCT01812200Phase 4
- Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study ProgrammeCompletedNCT01809015
- Canakinumab for the Prevention of Recurrences After Electrical Cardioversion: CONVERT-AFTerminatedNCT01805960Phase 2
- Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) IndicationCompletedNCT01805531
- Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial FibrillationCompletedNCT01803438Phase 4
- Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA RegionCompletedNCT01800006
- Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic FunctionCompletedNCT01796093
- The Effect of Simulated Obstructive Apnoea and Hypopnoea on Heart Rhythm in Patients With Paroxysmal Atrial FibrillationCompletedNCT01796080Not applicable
- Assays for and Reversal of New AnticoagulantsCompletedNCT01795781
- Thoracoscopic Versus Endocardial Ablation in Patient With Paroxysmal AF After Failed Initial Endocardial AblationCompletedNCT01794416Phase 2
- Assessment of Atrial Tissue Obtained From Patients Undergoing Heart Surgery and Tissue BankingCompletedNCT01793623
- Moxonidine for Prevention of Post-ablation AFib RecurrencesCompletedNCT01791699Phase 4
- Surgical Pulmonary Vein Isolation Efficiency StudyTerminatedNCT01791218Not applicable
- Is a Low Thyreotropin Level Predictive of Recurrent Arrhythmia After Catheter Ablative Surgery?CompletedNCT01789541
- Effects of Mediyoga in Patients With Paroxysmal Atrial FibrillationCompletedNCT01789372
- AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up ProtocolCompletedNCT01786486
- Statin Therapy In Atrial Refractoriness and Reperfusion InjuryCompletedNCT01780740Phase 4
- Atrial Fibrillation/Sinus Rhythm Before and After CardioversionCompletedNCT01779674
- Efficacy of Pilsicainide After Radiofrequency Ablation of Paroxysmal Atrial FibrillationStatus unknownNCT01775891Not applicable
- Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX SystemsCompletedNCT01774357
- Atrial Fibrillation Recurrence After Cryoballoon AblationCompletedNCT01772030Not applicable
- EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensity Focused UltrasoundCompletedNCT01769287
- PRECISION GOLD Post Market Study in Europe of Pulmonary Vein Ablation Catheter (PVAC GOLD)CompletedNCT01767558Not applicable
- Signal Transfer of Atrial Fibrillation Data to Guide Human TreatmentCompletedNCT01765075
- the Study of STABLE_SR for Persistent Atrial FibrillationStatus unknownNCT01761188Not applicable
- Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)CompletedNCT01751607
- Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in AsiaCompletedNCT01750788
- ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)Status unknownNCT01748253Not applicable
- Anticoagulation With Rivaroxaban in Cardioversion -The ARC StudyCompletedNCT01747746Phase 4
- Prevention of Postoperative Atrial FibrillationCompletedNCT01742039
- Clinical Value of Remote Ischemic PreconditioningCompletedNCT01740102Not applicable
- IntegRAted Chronic Care Program at Specialized AF Clinic Versus Usual CarE in Patients With Atrial Fibrillation - RACE4CompletedNCT01740037Not applicable
- Stroke Prevention and Rhythm Interventions in Atrial FibrillationCompletedNCT01733160
- Comparison of Pulmonary Vein Isolation Using SmartTouch® Catheter With or Without Real-time Contact Force DataCompletedNCT01730924Not applicable
- BioMonitor Master StudyCompletedNCT01725568
- Unexcitability Along the Ablation as an Endpoint for Atrial Fibrillation AblationCompletedNCT01724437Not applicable
- Effects of Exercise Training in Patients With Permanent Atrial FibrillationCompletedNCT01721863Phase 1
- Screening Versus Routine Practice in Detection of Atrial Fibrillation in the Elderly Population of LietoStatus unknownNCT01721005Not applicable
- Effect of Thoracic Epidural Analgesia for Thoracotomy on the Occurrence of AFStatus unknownNCT01718717Not applicable
- Left Atrium Substrate Based Ablation Plus Circumferential Pulmonary Vein Isolation to Treat Chronic Atrial FibrillationStatus unknownNCT01716143Not applicable
- Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial FibrillationStatus unknownNCT01713270Not applicable
- Benefit of CFAE AblationCompletedNCT01711047Not applicable
- Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial FibrillationCompletedNCT01710852Phase 2
- Pulmonary Vein Isolation To Reduce Future Risk Of Atrial Fibrillation In Patients Undergoing Typical FlutterWithdrawnNCT01710150Not applicable
- A Comparison of the Drug Therapy Versus Re-AblationCompletedNCT01709682Phase 2
- Ganglionated Plexi Ablation Combined With Pulmonary Vein IsolationCompletedNCT01703247Phase 2
- Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)CompletedNCT01701817
- Evaluation of a New Cardiac PacemakerStatus unknownNCT01700244Not applicable
- Does Atrial Fibrillation (AF) Termination Without Additional Ablation Influence Outcome?Status unknownNCT01696344
- Multi-electrode PulmonarY Vein Isolation Versus Single Tip Wide Area Catheter Ablation for Paroxysmal Atrial Fibrillation (PAF)CompletedNCT01696136Not applicable
- Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial FibrillationCompletedNCT01695824Phase 2
- Safety and Efficacy of Left Atrial Appendage Occlusion DevicesCompletedNCT01695564
- Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac MonitorCompletedNCT01694394
- Atrial Fibrillation Force Contact Ablation StudyCompletedNCT01693107
- CPVI Plus Renal Sympathetic Modification Versus CPVI Alone for AF（Atrial Fibrillation） AblationStatus unknownNCT01686542Not applicable
- Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart BeatsTerminatedNCT01683045Not applicable
- Study of Left Atrial Appendage Closure in Patients With Atrial Fibrillation - IIIWithdrawnNCT01680757Phase 4
- Effect of 3 Years of Exercise on Development of Atrial FibrillationActive, not recruitingNCT01680302Not applicable
- Prospective Registration and Assessment of Serious Adverse Events Within the AFNETCompletedNCT01678456
- THERMOCOOL® SMARTTOUCH™ RegistryCompletedNCT01677052
- Effect of 3 Years of Exercise in Patients With Atrial FibrillationCompletedNCT01673139Not applicable
- PV Reconnection After PVAI at Different Power Settings and Adenosine ProvocationStatus unknownNCT01672346Phase 3
- Pulmonary Vein Antrum Isolation (PVAI) Plus Scar Homogenization and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial FibrillationStatus unknownNCT01672138Not applicable
- Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney DiseaseWithdrawnNCT01668901Phase 4
- Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall IsolationCompletedNCT01660100Not applicable
- Rate Control in Atrial FibrillationCompletedNCT01655303Phase 4
- Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients IIWithdrawnNCT01654042Phase 3
- Comparison of Treatment of Atrial Fibrillation (AF) Between Surgical Ultrasonic Technology or Drug Therapy for Patients With AF Requiring Mitral Valve SurgeryTerminatedNCT01649544Not applicable
- A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.TerminatedNCT01647620Phase 1
- Vernakalant Versus Flecainide: Atrial ContractilityStatus unknownNCT01646281Phase 4
- Durability of Pulmonary Vein Isolation Following Cryoablation for Treatment of Paroxysmal Atrial FibrillationCompletedNCT01645917Phase 4
- Hybrid AF -- A Prospective RegistryWithdrawnNCT01636518
- Contact Force Sensing Use in Atrial Fibrillation AblationStatus unknownNCT01630330Not applicable
- Contact Force Sensing and Pulmonary Vein IsolationStatus unknownNCT01630031
- Ventricular Wall Motion CharacterizationCompletedNCT01629160
- The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation AblationCompletedNCT01629056Phase 4
- A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)WithdrawnNCT01627106Phase 4
- Hybrid Staged Operating Room and Interventional Catheter Ablation for Atrial FibrillationStatus unknownNCT01622907
- Cryoballoon Ablation of Pulmonary Veins After Failed RF Ablation in Patients With Paroxysmal AFCompletedNCT01611701Phase 3
- Applying Pharmacogenetics to Warfarin Dosing in Chinese PatientsStatus unknownNCT01610141Phase 4
- Carvedilol for Prevention of Paroxysmal Atrial FibrillationActive, not recruitingNCT01608893Not applicable
- Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial FibrillationWithdrawnNCT01607359
- Xarelto for Prevention of Stroke in Patients With Atrial FibrillationCompletedNCT01606995
- Xarelto [SPAF-QOL] Post-marketing Surveillance in JapanCompletedNCT01598051
- Ability of Home Monitoring® to Detect and Manage the Inappropriate Diagnoses in Implantable Cardioverter Defibrillators.CompletedNCT01594112
- Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, SwedenStatus unknownNCT01593553Not applicable
- Early Versus Late DC-cardioversion of Persistent Atrial Fibrillation. Effect on Atrial Remodeling,Inflammatory and Neurohumoral Markers and Recurrence of Atrial FibrillationCompletedNCT01593150Not applicable
- Catheter Contact Force and ElectrogramsCompletedNCT01587404Phase 4
- Manual vs Amigo SmartTouch Atrial Fibrillation StudyCompletedNCT01583855Not applicable
- Pulmonary Vein Ablation of Atrial Fibrillation Using Magnetic Navigation: Single Ring Versus Circumferential TechniquesCompletedNCT01583075Not applicable
- Serial Hybrid Atrial Fibrillation AblationWithdrawnNCT01582828Not applicable
- SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)Status unknownNCT01581502
- Vitamin C and Atrial Fibrillation After Cardiac SurgeryWithdrawnNCT01580683Phase 3
- CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation Versus Defragmentation. The CHASE-AF StudyCompletedNCT01580124Not applicable
- Statin Therapy In Cardiac SurgeryCompletedNCT01573143Phase 4
- Atorvastatin Using as a Possible Prophylaxis of Postoperative Atrial Fibrillation After Cardiac SurgeryTerminatedNCT01570530Phase 3